Compare Amphastar Pharmaceuticals Inc (AMPH) vs Nasdaq100 ETF (QQQ) Price & Performance

Amphastar Pharmaceuticals IncTrade

Nasdaq100 ETFTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Nasdaq100 ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Nasdaq100 ETF trades at $723.1. The key difference: Nasdaq100 ETF is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

	AMPH	QQQ
Market Cap	$868.62M	—
Sector	Health	—
52-Week High	$30.81	$746.16
52-Week Low	$16.87	$558.34
Enterprise Value	$1.27B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

AMPH

View details →

QQQ

JEPQ’s high yield comes with costly ordinary income taxes and capped gains, hurting taxable investors.24/7 Wall Street · 17 hours agoBearish Invesco QQQ ETF costs more than its cheaper clone QQQM despite identical holdings.24/7 Wall Street · 1 day agoNeutral JPMorgan's JEPQ ETF offers Nasdaq exposure with monthly income and less volatility.24/7 Wall Street · 3 days agoNeutral View details →

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.